Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is the FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
Símbolo de cotizaciónINSP
Nombre de la empresaInspire Medical Systems Inc
Fecha de salida a bolsaMay 03, 2018
Director ejecutivoMr. Timothy P. (Tim) Herbert
Número de empleados1246
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 03
Dirección5500 Wayzata Blvd Ste 1600
CiudadGOLDEN VALLEY
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal55416-1237
Teléfono17639575037
Sitio Webhttps://www.inspiresleep.com/
Símbolo de cotizaciónINSP
Fecha de salida a bolsaMay 03, 2018
Director ejecutivoMr. Timothy P. (Tim) Herbert
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos